Lilly drug heads to trials’ 3rd phase – Indianapolis Star – United States, Indianapolis – A third set of clinical trials for a possible Alzheimer’s treatment is about to get under way, Eli Lilly and Co. said Thursday … See all stories on this topic

Cholesterol drug cuts amputation risk for diabetics – Reuters – USA – … led by Anthony Keech and Kushwin Rajamani at the National Health and Medical Research Council Clinical Trials Center, University of Sydney, Australia. … See all stories on this topic

Study finds most clinical trials use erroneous data – Healthcare Republic – USA – Calculations of sample size are correctly reported in just one in three clinical trial publications, according to new research … – See all stories on this topic

Sanofi-Aventis Discontinues 14 Drugs in Clinical Trials – FDA news (subscription) – Falls Church, VA, USA – Development of 14 Sanofi-Aventis drugs already in clinical trials is being shut down following a company review of its R&D portfolio … See all stories on this topic

Researchers Start New Anti-Cancer Drug Trial – eMaxHealth.com – Hickory, NC, USA – Cancer Research UK and Cancer Research Technology (CRT) today announced they will begin a phase 1 clinical trial of an anti-cancer drug from GlaxoSmithKline … See all stories on this topic

polymedix Receives Regulatory Clearance to Initiate Second Phase I … Business Wire (press release) – San Francisco, CA, USA – This second Phase I clinical trial will assess the safety of PMX-30063 given repeatedly over a period of several days. Healthy volunteers will each receive … See all stories on this topic

Lilly starts big studies for Alzheimer’s candidate – Reuters – USA – … said on Thursday that it had advanced a second experimental treatment for Alzheimer’s disease into late-stage clinical trials … See all stories on this topic

Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing – Business Wire (press release) – San Francisco, CA, USA – “Avid made tremendous progress through its clinical trials since our last fundraising in May 2007,” said Daniel M. Skovronsky, MD, Ph.D., Founder and CEO of … See all stories on this topic

Lilly Advances Second Alzheimer’s Disease Treatment Candidate Into … PR Newswire (press release) – New York, NY, USA – In 2008, Lilly began enrolling patients in two Phase III clinical trials called IDENTITY and IDENTITY 2 for a different potential treatment for Alzheimer’s … See all stories on this topic